PharmAthene, Inc. (NYSE:PIP) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 1,888,701 shares, a drop of 11.8% from the August 31st total of 2,142,444 shares. Approximately 3.0% of the company’s shares are sold short. Based on an average daily volume of 155,491 shares, the short-interest ratio is currently 12.1 days.
PharmAthene (NYSE:PIP) opened at 2.82 on Friday. The firm’s 50-day moving average is $2.68 and its 200-day moving average is $2.39. The stock has a market cap of $184.97 million and a P/E ratio of 45.48. PharmAthene has a 1-year low of $1.31 and a 1-year high of $2.92.
Separately, TheStreet raised shares of PharmAthene from a “sell” rating to a “hold” rating in a research note on Wednesday, August 10th.
PharmAthene Company Profile
Pharmathene, Inc (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company’s anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes.
Receive News & Ratings for PharmAthene Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmAthene Inc. and related companies with MarketBeat.com's FREE daily email newsletter.